http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2633315-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e06beaed74fe991a30406301cd865466 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5058 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5085 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 |
| filingDate | 2011-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1359746daaf1008de08d9eeea4c76894 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c7e7d85929e654112c1f7675b0e1d25 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d597a911e3ee32ed3f11884a28d05e91 |
| publicationDate | 2013-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2633315-A1 |
| titleOfInvention | Insect-based ex vivo model for testing blood-brain barrier penetration and method for exposing insect brain to nanoparticles |
| abstract | There is provided an ex-vivo insect screening model to accurately determine blood-brain barrier penetration of different nanoparticles in order to improve the compound screening procedures/processes in the early drug discovery process. This object offers many advantages relative to prior technologies since insect models are more reliable tools for the decision-making process than the existing in vitro models, and will speed up the drug screening process and reduce the late phase attrition rate. Moreover, it will reduce the number of mammals sacrificed during the drug discovery phase. |
| priorityDate | 2010-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 43.